Aberrant Expression of COT Is Related to Recurrence of Papillary Thyroid Cancer

Aberrant expression of Cancer Osaka Thyroid Oncogene mitogen-activated protein kinase kinase kinase 8 (COT) (MAP3K8) is a driver of resistance to B-RAF inhibition. However, the de novo expression and clinical implications of COT in papillary thyroid cancer (PTC) have not been investigated. The aim o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jandee, Jeong, Seonhyang, Park, Jae Hyun, Lee, Cho Rok, Ku, Cheol Ryong, Kang, Sang-Wook, Jeong, Jong Ju, Nam, Kee-Hyun, Shin, Dong Yeob, Lee, Eun Jig, Chung, Woong Youn, Jo, Young Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602754/
https://www.ncbi.nlm.nih.gov/pubmed/25674762
http://dx.doi.org/10.1097/MD.0000000000000548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602754/
https://www.ncbi.nlm.nih.gov/pubmed/25674762
http://dx.doi.org/10.1097/MD.0000000000000548

Ejemplares similares